Great news yet again! It is now Moderna who is announcing that it’s coronavirus vaccine is 94.5%. This after an analysis of its clinical trial. Like Pfizer’s vaccine, this was done through an independent group. And like Pfizer, it was done during phase three of its study, which Moderna has called the COVE study.
The study enrolled more than 30,000 volunteers and had a group who was administered the placebo, and another who received the vaccine. This vaccine is also administered in two doses, 28 days apart. However, the Moderna studies waits 14 days after the second dose is administered to start counting cases, while Pfizer waits only seven.
After the waiting period there were 95 cases, 90 coming from the placebo group and only five from the vaccinated group. Out of the 90 cases in patients who were administered the placebo, 11 were severe. That gives the vaccine a 94.5% efficacy.
“This positive interim analysis from our Phase 3 study has given us the first clinical validation that our vaccine can prevent COVID-19 disease, including severe disease,” said Stéphane Bancel, chief executive officer of Moderna, in a statement.
This vaccine, as well as Pfizer’s, are being created with new mRNA technology. This type of vaccine contains the code to create the coronavirus spike protein, key component to infect the cells. It is also what triggers a person’s immune system to create antibodies. The difference is it will not cause an infection because the rest of the virus is missing. The FDA has yet to approve a vaccine with this technology, still, Moderna plans to file with the FDA to be considered for emergency use.
Why is this great news? Because it means we’re even closer to gathering once again. To be able to enjoy our favorite sports and live events. It means we’ll soon be calling up friends and asking them “what’s going on tonight?” Without hesitation or fear for our health. It means Tyket can move forward in innovating the live entertainment experience with membership that include tons of perks, connecting artists and producers like never before, and keeping a finger on the pulse of all live entertainment.
If you ever considered investing in StageWood, this is the news that you’d want to hear. This means that all of our objectives are clearer than ever, and our goals attainable. We’ll soon be on the other side of this, enjoying our favorite artist live and cheering our favorite team. Go ahead, invest in live entertainment today.